On September 30, 2026, Morgan Stanley disposed of 200,567 H shares of NOVOSENSE via the exercise of cash-settled equity derivatives (an off-exchange derivative transaction, not a direct dealing in the underlying shares), reducing its notifiable interest.
Prior to the disposal, Morgan Stanley's long position in NOVOSENSE was 1.18 million shares, representing 5.88%; following the disposal, the holding changed to 981,900 shares, with the long position ratio falling to 4.88%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.